December 1, 2020 Portfolio News from ARCH Venture Partners | Share Resilience – Raging at the Pandemic, a VC raises $800M for a Company That Aims to Transform Biotech Manufacturing
December 1, 2020 Media Coverage from ARCH Venture Partners | Share Co-Founder and Managing Director, Robert Nelsen, on AstraZeneca and His Plan to Revolutionize Biotech
July 30, 2020 Media Coverage from ARCH Venture Partners | Share Co-Founder and Managing Director, Robert Nelsen, Discusses Commitment to Infectious Disease Investing and its Implications amid COVID-19
July 15, 2020 Portfolio News from ARCH Venture Partners | Share Beam Therapeutics – This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect
June 2, 2020 Portfolio News from ARCH Venture Partners | Share Vir – Antibody from SARS Survivor Neutralizes SARS-CoV-2 Live Virus Infection of Cells
June 2, 2020 Portfolio News from ARCH Venture Partners | Share Mindstrong Raises $100M in Series C Round of Financing
April 27, 2020 Portfolio News from ARCH Venture Partners | Share Rome Therapeutics Launches with $50M to Tackle Small-Molecule Drugs for Cancer
April 14, 2020 Media Coverage from ARCH Venture Partners | Share ARCH Venture Partners Named to Forbes’ Midas List
April 14, 2020 Media Coverage from ARCH Venture Partners | Share ARCH Managing Director, Kristina Burow, Named to the 2020 Midas Brink List
April 14, 2020 Media Coverage from ARCH Venture Partners | Share ARCH Managing Director, Kristina Burow, Discusses Healthcare in a Post-Coronavirus World
April 6, 2020 Portfolio News from ARCH Venture Partners | Share GlaxoSmithKline and ARCH-backed Vir Aim to Take on Covid-19 with Antibodies and CRISPR
